Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Celltrion Launches Human Clinical Trial Of Potential Covid-19 Antiviral Antibody Treatment Following Positive Pre-Clinical Results

July 17 (Reuters) - Celltrion Inc  068270.KS :
    * CELLTRION LAUNCHES HUMAN CLINICAL TRIAL OF POTENTIAL
COVID-19
ANTIVIRAL ANTIBODY TREATMENT FOLLOWING POSITIVE PRE-CLINICAL
RESULTS
    * CELLTRION GROUP - PHASE I STUDY OF COVID-19 ANTIVIRAL
ANTIBODY
TREATMENT CANDIDATE IN HEALTHY VOLUNTEERS IS SET FOR COMPLETION
BY Q3
    * CELLTRION GROUP - ANTICIPATES PROMISING PRELIMINARY
RESULTS FROM
PIVOTAL STUDIES IN MILD, MODERATE COVID-19 PATIENTS BY END OF
YEAR
    * CELLTRION GROUP - FURTHER HUMAN STUDIES ACROSS EUROPE
INCLUDING
UK ARE PLANNED

Source text for Eikon:  ID:nBw8M4L5Na 
Further company coverage:  068270.KS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news